Sharif Koep, Pharm.D.

Global Medical Affairs Director at Y-mAbs Therapeutics

Sharif Koep, Pharm.D. has a diverse work experience in the pharmaceutical industry. Sharif currently works at Y-mAbs Therapeutics, Inc. as the Medical Affairs Lead for Immunotherapy. Prior to this role, they served as the Scientific and Operations Lead for Oncology and Immunotherapy at the same company. Sharif also worked as a Medical Science Liaison in Oncology at Y-mAbs Therapeutics from 2020 to 2022.

Before joining Y-mAbs Therapeutics, Sharif worked at Novartis as a Medical Science Liaison Associate Director in Immunology and Dermatology from 2018 to 2020. Sharif also served as a Medical Science Liaison in Rheumatology, Immunology, and Dermatology at Novartis from 2015 to 2020.

Earlier in their career, Sharif held the position of Director of Operations at Biovest International, Inc. where they were responsible for managing various aspects of the company's autologous cancer vaccine production. Sharif had a key role in presenting clinical perspectives to regulatory agencies and conducting market research projects.

Sharif's work experience also includes a role as a Pharmacist at CVS Caremark Corporation, where they provided medication counseling to patients, collaborated with physicians, and ensured the accuracy of medication dispensed. Additionally, they worked as a Boxing Trainer at RocBoxing, showcasing their versatility outside the pharmaceutical field.

Overall, Sharif Koep, Pharm.D. has a strong background in medical affairs, operations, and liaison roles in the pharmaceutical industry, demonstrating their expertise and versatility in different areas of healthcare.

Sharif Koep, Pharm.D. earned their Bachelor of Science degree in Chemistry from the University of Minnesota in 2008. Sharif then pursued further education and obtained their Doctor of Pharmacy (PharmD) degree from St. John Fisher University in 2013, specializing in the field of Pharmacy.

Links

Previous companies

CVS Health logo
Novartis logo

Timeline

  • Global Medical Affairs Director

    July 1, 2024 - present

  • Medical Affairs Lead, Immunotherapy

    June, 2022

  • Scientific and Operations Lead - Oncology, Immunotherapy

    January, 2022

  • Medical Science Liaison - Oncology

    January, 2020